Qube Research & Technologies (QRT)’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
368,030
+72,689
| +25% | +$225K | ﹤0.01% | 1748 |
|
|
2025
Q1 | $1.03M | Sell |
295,341
-94,996
| -24% | -$332K | ﹤0.01% | 1751 |
|
|
2024
Q4 | $1.28M | Buy |
390,337
+220,050
| +129% | +$720K | ﹤0.01% | 1646 |
|
|
2024
Q3 | $656K | Buy |
+170,287
| New | +$656K | ﹤0.01% | 1806 |
|
|
2024
Q1 | – | Sell |
-1,685
| Closed | -$4.21K | – | 3885 |
|
|
2023
Q4 | $4.21K | Sell |
1,685
-6,527
| -79% | -$16.3K | ﹤0.01% | 3310 |
|
|
2023
Q3 | $16.7K | Sell |
8,212
-8,966
| -52% | -$18.2K | ﹤0.01% | 2763 |
|
|
2023
Q2 | $39.5K | Sell |
17,178
-4,846
| -22% | -$11.1K | ﹤0.01% | 2017 |
|
|
2023
Q1 | $66.7K | Buy |
+22,024
| New | +$66.7K | ﹤0.01% | 2125 |
|
|
2021
Q3 | – | Sell |
-15,474
| Closed | -$47K | – | 2128 |
|
|
2021
Q2 | $47K | Sell |
15,474
-105,055
| -87% | -$319K | ﹤0.01% | 2018 |
|
|
2021
Q1 | $401K | Sell |
120,529
-263,768
| -69% | -$878K | 0.01% | 1302 |
|
|
2020
Q4 | $1.36M | Buy |
384,297
+343,223
| +836% | +$1.22M | 0.02% | 762 |
|
|
2020
Q3 | $129K | Sell |
41,074
-17,839
| -30% | -$56K | ﹤0.01% | 1463 |
|
|
2020
Q2 | $107K | Buy |
58,913
+14,994
| +34% | +$27.2K | ﹤0.01% | 1504 |
|
|
2020
Q1 | $44K | Sell |
43,919
-122,219
| -74% | -$122K | ﹤0.01% | 1019 |
|
|
2019
Q4 | $462K | Buy |
+166,138
| New | +$462K | 0.01% | 987 |
|